Evidence Search

Management of Pigmented Villonodular Synovitis (PVNS): an Orthopedic Surgeon's Perspective.

Current oncology reports | 2020 | Bernthal NM, Ishmael CR, Burke ZDC

[Indexed for MEDLINE] 2. BMC Med. 2025 Sep 1;23(1):513. doi: 10.1186/s12916-025-04358-7. Proteomics and metabolomics studies in pigmented villonodular synovitis uncover the regulation of monocyte differentiation by the ADGRE5-NF-κB pathway. Ge M(#)(1), Yang R(#)(1), Xu B(#)(1), Fan L(1), Xu M(2), Xu T(1), Li J(1), Li Y(3)(4), Gong M(5), Fu W(6). Author information: (1)Sports Me...

Locally Aggressive Connective Tissue Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018 | Gounder MM, Thomas DM, Tap WD

[Indexed for MEDLINE] 10. Knee. 2025 Oct;56:407-414. doi: 10.1016/j.knee.2025.06.006. Epub 2025 Jul 5. Current management of Tenosynovial Giant Cell Tumours of the knee in the United Kingdom. Ward TRW(1), Ashford RU(2), Eastley NC(2). Author information: (1)University Hospitals of Leicester NHS Trust, United Kingdom. Electronic address: Thomasrwward@doctors.org.uk. (2)Universit...

Giant Cell Tumor in Tarsal Midfoot Bones: A Case Report.

Cureus | 2024 | Abed Alharbi W, Mohammed Alshareef H, Hennawi YB, Munshi AA

Conflict of interest statement: The authors have declared that no competing interests exist. 4. J Inflamm Res. 2025 Dec 8;18:17129-17142. doi: 10.2147/JIR.S549953. eCollection 2025. Mechanistic Study of CD90-Positive Synovial Fibroblasts in the Invasion and Recurrence of Pigmented Villonodular Synovitis. Kong L(#)(1), Chen H(#)(1), Zhang H(#)(2), Zhang X(3), Chen J(1), Nie Y(1)...

A rare case of long-term joint swelling caused by pigmented villonodular synovitis in a 3-year-old girl: a case report.

Frontiers in surgery | 2023 | Liu Y, Liang S, Wang W

Conflict of interest statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. 17. Cancer. 2012 Mar 15;118(6):1649-55. doi: 10.1002/cncr.26409. Epub 2011 Aug 5. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosyn...

Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee with Concurrent Polymicrobial Infection (Klebsiella oxytoca and Group B Streptococcus).

Case reports in infectious diseases | 2021 | Marshall JH, Skedros JG, Campana CF, Seibert AM

Conflict of interest statement: The authors declare no conflicts of interest. 15. Curr Opin Oncol. 2011 Jul;23(4):361-6. doi: 10.1097/CCO.0b013e328347e1e3. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis. Ravi V(1), Wang WL, Lewis VO. Author information: (1)Department of Sarcoma Medical Oncology, UT MD Anderson Cancer Center, Houston, Texas 77030...

Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.

Current opinion in oncology | 2011 | Ravi V, Wang WL, Lewis VO

[Indexed for MEDLINE] 16. Front Surg. 2023 May 11;10:1075171. doi: 10.3389/fsurg.2023.1075171. eCollection 2023. A rare case of long-term joint swelling caused by pigmented villonodular synovitis in a 3-year-old girl: a case report. Liu Y(#)(1)(2), Liang S(#)(1), Wang W(1). Author information: (1)Department of Orthopedics, Guangzhou Red Cross Hospital of Jinan University, Guang...

Functional Outcomes and Recurrence After Arthroscopy-Based Treatment of Pigmented Villonodular Synovitis of the Knee: A 20-Year Single-Center Series.

Cancers | 2026 | Konstantinou E, Koskiniotis A, Koutalos A, Malizos K

Conflict of interest statement: The authors declare no conflicts of interest. 19. Oncol Rep. 2000 Mar-Apr;7(2):413-9. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence. Martin RC 2nd(1), Osborne DL, Edwards MJ, Wrightson W, McMasters KM. Author information: (1)Divisi...

Proteomics and metabolomics studies in pigmented villonodular synovitis uncover the regulation of monocyte differentiation by the ADGRE5-NF-κB pathway.

BMC medicine | 2025 | Ge M, Yang R, Xu B, Fan L

[Indexed for MEDLINE] Conflict of interest statement: Declarations. Ethics approval and consent to participate.: The study received approval from the Ethics Committee on Biomedical Research at West China Hospital, Sichuan University (No. 125 2020-(921)). Informed consent was obtained from all participants before their involvement in the study. Consent for publication: Not appli...

Mechanistic Study of CD90-Positive Synovial Fibroblasts in the Invasion and Recurrence of Pigmented Villonodular Synovitis.

Journal of inflammation research | 2025 | Kong L, Chen H, Zhang H, Zhang X

Conflict of interest statement: The authors declare that they have no competing interests. 5. Ortop Traumatol Rehabil. 2017 Jan 26;19(1):79-88. doi: 10.5604/15093492.1235281. Pigmented Villonodular Synovitis - Various Manifestations, Inconsistent Terminology and Treatment. Cases Study. Kokoszka P(1), Woźniak W(1), Łapaj Ł(1), Kruczyński J(1). Author information: (1)Department o...

Current management of Tenosynovial Giant Cell Tumours of the knee in the United Kingdom.

The Knee | 2025 | Ward TRW, Ashford RU, Eastley NC

[Indexed for MEDLINE] Conflict of interest statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. 11. JBJS Essent Surg Tech. 2022 May 25;12(2):e21.00035. doi: 10.2106/JBJS.ST.21.00035. eCollection 2022 Apr-Jun. Extensil...

Tenosynovial giant cell tumours of the foot and ankle: a retrospective single centre experience with surgical treatment of 34 cases.

BMC cancer | 2025 | Scheele C, Harrasser N, Beischl S, Dammerer D

[Indexed for MEDLINE] Conflict of interest statement: Declarations. Ethics approval and consent to participate: Approval of local ethics committee (TU Munich) was obtained (no. 2023-103-S-KH). All patients signed an informed consent form. Consent for publication: All authors agreed to publish. Competing interests: The authors declare no competing interests. 14. Case Rep Infect...

Patient Outcomes After Resection of Pigmented Villonodular Synovitis in Patients in King Abdulaziz Medical City.

Cureus | 2024 | Aljuhani W, Alamri A, Altorbak B, Alabbasi J

Conflict of interest statement: Human subjects: Consent was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared th...

Pigmented villonodular synovitis (PVNS)

Radiopaedia.org | 2024 | Tariq Walizai

Pigmented Villonodular Synovitis - Various Manifestations, Inconsistent Terminology and Treatment. Cases Study.

Ortopedia, traumatologia, rehabilitacja | 2017 | Kokoszka P, Woźniak W, Łapaj Ł, Kruczyński J

[Indexed for MEDLINE] 6. Clin Ther. 2016 Apr;38(4):778-93. doi: 10.1016/j.clinthera.2016.03.008. Epub 2016 Apr 1. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors. Gelhorn HL(1), Tong S(2), McQuarrie K(3), Vernon C(3), Hanlon J(3), Maclaine G(4), Lenderking W(3), Ye X(5), Speck RM(3), Lackman RD(6), Bukata SV(7), Healey JH(8), Keedy VL(9), Anthony SP(10), Wagner AJ(1...

Chondroid Tenosynovial Giant Cell Tumor of the Temporomandibular Joint: A Rare Case Report.

Brazilian dental journal | 2017 | Anbinder AL, Geraldo BMC, Guimarães R Filho, Pereira DL

[Indexed for MEDLINE] 9. J Clin Oncol. 2018 Jan 10;36(2):202-209. doi: 10.1200/JCO.2017.75.8482. Epub 2017 Dec 8. Locally Aggressive Connective Tissue Tumors. Gounder MM(1), Thomas DM(1), Tap WD(1). Author information: (1)Mrinal M. Gounder and William D. Tap, Memorial Sloan Kettering Cancer Center and Weil Cornell Medical School, New York, NY; and David M. Thomas, Garvan Instit...

Extensile Anterior and Posterior Knee Exposure for Complete Synovectomy of Diffuse Tenosynovial Giant Cell Tumor (Pigmented Villonodular Synovitis).

JBJS essential surgical techniques | 2022 | Lingamfelter M, Novaczyk ZB, Cheng EY

Conflict of interest statement: Disclosure: The Disclosure of Potential Conflicts of Interest forms are provided with the online version of the article (http://links.lww.com/JBJSEST/A371). 12. Knee Surg Sports Traumatol Arthrosc. 2018 Nov;26(11):3508-3514. doi: 10.1007/s00167-018-4942-2. Epub 2018 Apr 10. Distinct extra-articular invasion patterns of diffuse pigmented villonodu...

Clinical benefit of imatinib in patients with relapsed tenosynovial giant cell tumor/pigmented villonodular synovitis (TGCT/PVNS).

Journal of Clinical Oncology | 2022 | Jeanette Cu Yu, Manpreet Kaur Sidhu, Andrew Fang, Lee Jae Morse

e23561 Background: TGCT/PVNS is an uncommon benign but locally aggressive tumor that affects joints and can lead to significant morbidity. It is characterized in most cases by a t(1;2) translocation that leads to overexpression of colony-stimulating factor 1 (CSF-1) and the accumulation of inflammatory cells that express CSF-1 receptor (CSF-1R) in the affected joints. Imatinib...

Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis

Sarcomas | 2020 | Edward Y. Cheng, Christian M. Ogilvie, Paari Murugan

Pigmented Villonodular Synovitis and Giant Cell Tumor of the Tendon Sheaths (Tenosynovial Giant Cell Tumor)

Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions | 2020 | Eric L. Staals

Pigmented villonodular synovitis (PVNS)

Radiopaedia.org | 2019 | Mahmoud Mekhaimar

Pigmented villonodular synovitis (PVNS) - focal

Radiopaedia.org | 2019 | Bahman Rasuli

Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA | 2018 | Kim DE, Kim JM, Lee BS, Kim NK

[Indexed for MEDLINE] 13. BMC Cancer. 2025 Mar 23;25(1):530. doi: 10.1186/s12885-025-13921-7. Tenosynovial giant cell tumours of the foot and ankle: a retrospective single centre experience with surgical treatment of 34 cases. Scheele C(1), Harrasser N(2), Beischl S(2), Dammerer D(3), Lenze U(2), Knebel C(2), von Eisenhart-Rothe R(2), Lenze F(2). Author information: (1)Departme...

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.

Clinical therapeutics | 2016 | Gelhorn HL, Tong S, McQuarrie K, Vernon C

[Indexed for MEDLINE] Conflict of interest statement: CONFLICTS OF INTEREST G. Maclaine and X. Ye are employees of Daiichi Sankyo Development Ltd, which provided financial support for this research. S. Tong and P. Lin are employees of Plexxikon Inc, which provided financial support for this research. J.H. Healey is a paid consultant of Daiichi Sankyo Development Ltd. H. Hsu is...

Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.

Oncology reports | 2000 | Martin RC 2nd, Osborne DL, Edwards MJ, Wrightson W

[Indexed for MEDLINE] 20. AJNR Am J Neuroradiol. 2026 Aug 17:ajnr.A9595. doi: 10.3174/ajnr.A9595. Online ahead of print. Extra-articular extracranial extension of temporomandibular joint lesions: imaging patterns and diagnostic pitfalls-a systematic review. McKee H(1), Maizlin N(2), Shalal S(2), Tejani A(2), Lozano CS(2), Mosimann PJ(2), Germann J(2), Alshafai L(2), Hiremath SB...

pigmented villonodular synovitis (PVNS) Pigmented Villonodular Synovitis

Diagnostic Imaging of the Foot and Ankle | 2015

Pigmented Villonodular Synovitis (PVNS) and Giant-Cell Tumor of Tendon Sheath

Atlas of Musculoskeletal Tumors and Tumorlike Lesions | 2014 | Nicola Fabbri

Focal pigmented villonodular synovitis (PVNS)

Radiopaedia.org | 2013 | Mohammad ElBeialy

Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.

Cancer | 2012 | Cassier PA, Gelderblom H, Stacchiotti S, Thomas D

[Indexed for MEDLINE] 18. Cancers (Basel). 2026 Apr 7;18(7):1178. doi: 10.3390/cancers18071178. Functional Outcomes and Recurrence After Arthroscopy-Based Treatment of Pigmented Villonodular Synovitis of the Knee: A 20-Year Single-Center Series. Konstantinou E(1), Koskiniotis A(1), Koutalos A(1), Malizos K(1), Karachalios T(1), Hantes M(1). Author information: (1)Department of...

Tenosynovial giant cell tumor (TGCT)/pigmented villonodular synovitis (PVNS): Outcome of 313 patients before the era of kinase inhibitors.

Journal of Clinical Oncology | 2012 | Emanuela Palmerini, Stefano Pengo, Robert G. Maki, Eric L. Staals

10022 Background: Tenosynovial giant cell tumor (TGCT) is a rare, usually benign neoplasm of synovium and tendon sheath. TGCT is classified as localized or diffuse according to the extent of synovial involvement. Surgery is the primary treatment, but the recurrence rate is high, with possible multiple recurrences, joint function deterioration and decline in quality of life. Rec...

Imatinib mesylate for the treatment of locally advanced and/or metastatic pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).

Journal of Clinical Oncology | 2010 | P. A. Cassier, S. Stacchiotti, H. Gelderblom, D. M. Thomas

Pigmented villonodular synovitis (PVNS)

Radiopaedia.org | 2009 | Frank Gaillard

Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT)

Annals of Oncology | 2008 | J.-Y. Blay, H. El Sayadi, P. Thiesse, J. Garret

Tenosynovial giant cell tumor and pigmented villonodular synovitis

Skeletal Radiology | 2007 | Andrew L. Folpe

Pigmented villonodular synovitis (PVNS)

Journal unavailable | Andrea B. Rosskopf, Daniel A. Mueller